Indivior Pharmaceuticals (INDV) Net Cash Flow Growth (1y) (2025 - 2026)

Indivior Pharmaceuticals (INDV) Net Cash Flow Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Haleon 89.64 Bn 87.78 Bn - -
2 Teva Pharmaceutical Industries 35.90 Bn 32.16 Bn 1.97 Bn 112.26%
3 Zoetis 32.50 Bn 30.56 Bn 1.62 Bn -44.11%
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn 209.30%
5 United Therapeutics 22.98 Bn 20.83 Bn 648.10 Mn -236.85%
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.38 Bn 18.57 Bn 1.16 Bn 13,485.29%
8 Neurocrine Biosciences 17.78 Bn 16.46 Bn 800.70 Mn -1,047.81%
9 Elanco Animal Health 12.67 Bn 12.24 Bn 785.00 Mn -1,020.00%
10 Indivior Pharmaceuticals 5.00 Bn 4.83 Bn 277.00 Mn -139.62%

Historic Data

Download Data
DateValue
Mar 31, 2026 -139.62%
Dec 31, 2025 -906.45%
Sep 30, 2025 -342.86%
Jun 30, 2025 151.85%
Mar 31, 2025 177.94%